334 related articles for article (PubMed ID: 25627812)
1. Immune requirements for protective Th17 recall responses to Mycobacterium tuberculosis challenge.
Monin L; Griffiths KL; Slight S; Lin Y; Rangel-Moreno J; Khader SA
Mucosal Immunol; 2015 Sep; 8(5):1099-109. PubMed ID: 25627812
[TBL] [Abstract][Full Text] [Related]
2. Th1/Th17 cell induction and corresponding reduction in ATP consumption following vaccination with the novel Mycobacterium tuberculosis vaccine MVA85A.
Griffiths KL; Pathan AA; Minassian AM; Sander CR; Beveridge NE; Hill AV; Fletcher HA; McShane H
PLoS One; 2011; 6(8):e23463. PubMed ID: 21887254
[TBL] [Abstract][Full Text] [Related]
3. A lipidated peptide of Mycobacterium tuberculosis resuscitates the protective efficacy of BCG vaccine by evoking memory T cell immunity.
Rai PK; Chodisetti SB; Zeng W; Nadeem S; Maurya SK; Pahari S; Janmeja AK; Jackson DC; Agrewala JN
J Transl Med; 2017 Oct; 15(1):201. PubMed ID: 28985739
[TBL] [Abstract][Full Text] [Related]
4. Th17-related cytokines contribute to recall-like expansion/effector function of HMBPP-specific Vγ2Vδ2 T cells after Mycobacterium tuberculosis infection or vaccination.
Shen H; Wang Y; Chen CY; Frencher J; Huang D; Yang E; Ryan-Payseur B; Chen ZW
Eur J Immunol; 2015 Feb; 45(2):442-51. PubMed ID: 25141829
[TBL] [Abstract][Full Text] [Related]
5. IL-22 is mainly produced by IFNγ-secreting cells but is dispensable for host protection against Mycobacterium tuberculosis infection.
Behrends J; Renauld JC; Ehlers S; Hölscher C
PLoS One; 2013; 8(2):e57379. PubMed ID: 23460846
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-23 instructs protective multifunctional CD4 T cell responses after immunization with the Mycobacterium tuberculosis subunit vaccine H1 DDA/TDB independently of interleukin-17A.
Ritter K; Behrends J; Erdmann H; Rousseau J; Hölscher A; Volz J; Prinz I; Lindenstrøm T; Hölscher C
J Mol Med (Berl); 2021 Nov; 99(11):1585-1602. PubMed ID: 34351501
[TBL] [Abstract][Full Text] [Related]
7. A Promising Listeria-Vectored Vaccine Induces Th1-Type Immune Responses and Confers Protection Against Tuberculosis.
Yin Y; Lian K; Zhao D; Tao C; Chen X; Tan W; Wang X; Xu Z; Hu M; Rao Y; Zhou X; Pan Z; Zhang X; Jiao X
Front Cell Infect Microbiol; 2017; 7():407. PubMed ID: 29034213
[TBL] [Abstract][Full Text] [Related]
8. The glycosylated Rv1860 protein of Mycobacterium tuberculosis inhibits dendritic cell mediated TH1 and TH17 polarization of T cells and abrogates protective immunity conferred by BCG.
Satchidanandam V; Kumar N; Jumani RS; Challu V; Elangovan S; Khan NA
PLoS Pathog; 2014 Jun; 10(6):e1004176. PubMed ID: 24945624
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic efficacy of a tuberculosis DNA vaccine encoding heat shock protein 65 of Mycobacterium tuberculosis and the human interleukin 2 fusion gene.
Changhong S; Hai Z; Limei W; Jiaze A; Li X; Tingfen Z; Zhikai X; Yong Z
Tuberculosis (Edinb); 2009 Jan; 89(1):54-61. PubMed ID: 19056317
[TBL] [Abstract][Full Text] [Related]
10. Lactic acid bacteria enhance autophagic ability of mononuclear phagocytes by increasing Th1 autophagy-promoting cytokine (IFN-gamma) and nitric oxide (NO) levels and reducing Th2 autophagy-restraining cytokines (IL-4 and IL-13) in response to Mycobacterium tuberculosis antigen.
Ghadimi D; de Vrese M; Heller KJ; Schrezenmeir J
Int Immunopharmacol; 2010 Jun; 10(6):694-706. PubMed ID: 20381647
[TBL] [Abstract][Full Text] [Related]
11. The candidate TB vaccine, MVA85A, induces highly durable Th1 responses.
Tameris M; Geldenhuys H; Luabeya AK; Smit E; Hughes JE; Vermaak S; Hanekom WA; Hatherill M; Mahomed H; McShane H; Scriba TJ
PLoS One; 2014; 9(2):e87340. PubMed ID: 24498312
[TBL] [Abstract][Full Text] [Related]
12. Mycobacterium tuberculosis RpfE promotes simultaneous Th1- and Th17-type T-cell immunity via TLR4-dependent maturation of dendritic cells.
Choi HG; Kim WS; Back YW; Kim H; Kwon KW; Kim JS; Shin SJ; Kim HJ
Eur J Immunol; 2015 Jul; 45(7):1957-71. PubMed ID: 25907170
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-17-dependent CXCL13 mediates mucosal vaccine-induced immunity against tuberculosis.
Gopal R; Rangel-Moreno J; Slight S; Lin Y; Nawar HF; Fallert Junecko BA; Reinhart TA; Kolls J; Randall TD; Connell TD; Khader SA
Mucosal Immunol; 2013 Sep; 6(5):972-84. PubMed ID: 23299616
[TBL] [Abstract][Full Text] [Related]
14. PLGA particulate subunit tuberculosis vaccines promote humoral and Th17 responses but do not enhance control of Mycobacterium tuberculosis infection.
Ashhurst AS; Parumasivam T; Chan JGY; Lin LCW; Flórido M; West NP; Chan HK; Britton WJ
PLoS One; 2018; 13(3):e0194620. PubMed ID: 29554138
[TBL] [Abstract][Full Text] [Related]
15. Incorporation of immunostimulatory motifs in the transcribed region of a plasmid DNA vaccine enhances Th1 immune responses and therapeutic effect against Mycobacterium tuberculosis in mice.
Wu J; Ma H; Qu Q; Zhou WJ; Luo YP; Thangaraj H; Lowrie DB; Fan XY
Vaccine; 2011 Oct; 29(44):7624-30. PubMed ID: 21856352
[TBL] [Abstract][Full Text] [Related]
16. Mycobacterium bovis BCG-specific Th17 cells confer partial protection against Mycobacterium tuberculosis infection in the absence of gamma interferon.
Wozniak TM; Saunders BM; Ryan AA; Britton WJ
Infect Immun; 2010 Oct; 78(10):4187-94. PubMed ID: 20679438
[TBL] [Abstract][Full Text] [Related]
17. The effect of adjuvants and delivery systems on Th1, Th2, Th17 and Treg cytokine responses in mice immunized with Mycobacterium tuberculosis-specific proteins.
Safar HA; Mustafa AS; Amoudy HA; El-Hashim A
PLoS One; 2020; 15(2):e0228381. PubMed ID: 32027660
[TBL] [Abstract][Full Text] [Related]
18. A new recombinant BCG vaccine induces specific Th17 and Th1 effector cells with higher protective efficacy against tuberculosis.
da Costa AC; Costa-Júnior Ade O; de Oliveira FM; Nogueira SV; Rosa JD; Resende DP; Kipnis A; Junqueira-Kipnis AP
PLoS One; 2014; 9(11):e112848. PubMed ID: 25398087
[TBL] [Abstract][Full Text] [Related]
19. A Mycobacterium tuberculosis-specific subunit vaccine that provides synergistic immunity upon co-administration with Bacillus Calmette-Guérin.
Woodworth JS; Clemmensen HS; Battey H; Dijkman K; Lindenstrøm T; Laureano RS; Taplitz R; Morgan J; Aagaard C; Rosenkrands I; Lindestam Arlehamn CS; Andersen P; Mortensen R
Nat Commun; 2021 Nov; 12(1):6658. PubMed ID: 34795205
[TBL] [Abstract][Full Text] [Related]
20. Mycobacterium tuberculosis promotes Th17 expansion via regulation of human dendritic cells toward a high CD14 and low IL-12p70 phenotype that reprograms upon exogenous IFN-γ.
Søndergaard JN; Laursen JM; Rosholm LB; Brix S
Int Immunol; 2014 Dec; 26(12):705-16. PubMed ID: 25223368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
